QLC7401 in the Treatment of Primary Hypercholesterolemia or Mixed Hyperlipidemia With Elevated Low Density Lipoprotein Cholesterol (LDL-C)

NCT07441317 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

780

Enrollment

INDUSTRY

Sponsor class

Conditions

Primary Hypercholesterolemia or Mixed Hyperlipidemia

Interventions

DRUG: QLC7401
DRUG: Placebo

Sponsor

Qilu Pharmaceutical Co., Ltd.